ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 24 filers reported holding ADIAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $37,499 | -51.8% | 180,285 | -18.9% | 0.00% | – |
| Q1 2023 | $77,799 | +301.4% | 222,283 | +144.3% | 0.00% | – |
| Q4 2022 | $19,382 | -85.4% | 90,996 | -8.2% | 0.00% | – |
| Q2 2022 | $133,000 | +269.4% | 99,103 | +447.0% | 0.00% | – |
| Q1 2022 | $36,000 | -85.1% | 18,117 | -79.8% | 0.00% | – |
| Q4 2021 | $242,000 | +8.0% | 89,784 | +72.0% | 0.00% | – |
| Q3 2021 | $224,000 | +1144.4% | 52,200 | +280.6% | 0.00% | – |
| Q1 2020 | $18,000 | – | 13,714 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VANGUARD GROUP INC | 293,908 | $494,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 315 | $1,000 | 0.00% |
| UBS Group AG | 1,692 | $3,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 650 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 77,985 | $131,000 | 0.00% |
| DEUTSCHE BANK AG\ | 1,900 | $3,000 | 0.00% |
| MORGAN STANLEY | 535 | $1,000 | 0.00% |
| BROWN ADVISORY INC | 26,040 | $44,000 | 0.00% |
| BlackRock Inc. | 205,684 | $346,000 | 0.00% |